Supernus Pharmaceuticals Operating Expenses 2011-2024 | SUPN

Supernus Pharmaceuticals operating expenses from 2011 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
Supernus Pharmaceuticals Annual Operating Expenses
(Millions of US $)
2023 $613
2022 $621
2021 $494
2020 $347
2019 $244
2018 $264
2017 $203
2016 $161
2015 $127
2014 $98
2013 $74
2012 $44
2011 $39
2010 $40
Supernus Pharmaceuticals Quarterly Operating Expenses
(Millions of US $)
2024-09-30 $135
2024-06-30 $146
2024-03-31 $147
2023-12-31 $165
2023-09-30 $146
2023-06-30 $153
2023-03-31 $149
2022-12-31 $133
2022-09-30 $179
2022-06-30 $159
2022-03-31 $151
2021-12-31 $153
2021-09-30 $116
2021-06-30 $107
2021-03-31 $118
2020-12-31 $101
2020-09-30 $99
2020-06-30 $81
2020-03-31 $66
2019-12-31 $60
2019-09-30 $62
2019-06-30 $62
2019-03-31 $60
2018-12-31 $76
2018-09-30 $66
2018-06-30 $64
2018-03-31 $59
2017-12-31 $54
2017-09-30 $58
2017-06-30 $50
2017-03-31 $41
2016-12-31 $46
2016-09-30 $37
2016-06-30 $40
2016-03-31 $38
2015-12-31 $36
2015-09-30 $34
2015-06-30 $32
2015-03-31 $25
2014-12-31 $26
2014-09-30 $23
2014-06-30 $26
2014-03-31 $23
2013-12-31 $22
2013-09-30 $18
2013-06-30 $16
2013-03-31 $18
2012-12-31 $14
2012-09-30 $12
2012-06-30 $9
2012-03-31 $8
2011-12-31 $10
2011-09-30 $10
2011-06-30 $9
2011-03-31 $9
2010-12-31
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $1.962B $0.608B
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit hyperactivity disorder. Supernus Pharmaceuticals Inc. is based in Rockville, Maryland.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.044B 6.25
Dr Reddy's Laboratories (RDY) India $11.978B 22.92
BridgeBio Pharma (BBIO) United States $4.260B 0.00
Bausch Health Cos (BHC) Canada $3.012B 2.18
Amphastar Pharmaceuticals (AMPH) United States $2.097B 12.61
Taysha Gene Therapies (TSHA) United States $0.434B 30.29
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.098B 0.00
Sol-Gel Technologies (SLGL) Israel $0.012B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00